Skip to content

Replimune Group REPL Q3 2025 earnings

Reported February 12, 2025 · Before market open

Next report

Aug 6, 2026 (In 3 weeks)
Revenue estimate$13.6M
EPS estimate-$0.64

Financials

Q3 2025

Income statement

See full
Operating income-$66.0M-16.8%
Net income-$66.3M-29.8%
EPS (diluted)-$0.79-2.6%

Balance sheet

See full
Cash & equivalents$173.9M+75.2%
Total debt$78.8M+0.4%
Total equity$482.4M+14.4%
Total assets$603.6M+13.3%

Cash flow

See full
Operating cash flow-$50.7M-7.6%
CapEx$1.8M+4.7%
Free cash flow-$52.5M-7.5%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$931.93M+65.9%
Enterprise value$836.81M+54.7%

Returns & leverage

See full
Return on equity-50.5%+14.5pp
Debt / equity0.2×0.0×
Current ratio11.4×-1.0×

Versus estimates

Ask the moment Replimune Group reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Replimune Group report Q3 2025 earnings?
Replimune Group (REPL) reported Q3 2025 earnings on February 12, 2025 before market open.
What were Replimune Group's Q3 2025 revenue and EPS?
Replimune Group reported diluted EPS of $-0.79 for Q3 2025.
Did Replimune Group beat estimates in Q3 2025?
EPS missed the consensus estimate of $-0.70 by $0.09.
Where can I find Replimune Group's Q3 2025 SEC filings?
You can read the 10-Q periodic report (0001737953-25-000004) directly on SEC EDGAR. The filing index links above go to sec.gov.